Guided Therapeutics (GTHP) Intangibles (2010 - 2011)
Guided Therapeutics' (GTHP) quarterly Intangibles came in at $409000.0 in Q2 2011, up 36.79% quarter-over-quarter from $299000.0 in Q4 2010.
Guided Therapeutics (GTHP) Intangibles (2010 - 2011) Analysis & Trends
Guided Therapeutics has disclosed Intangibles across 2 years of filings, most recently posting $409000.0 for Q2 2011.
- Intangibles for Q2 2011 came in at $409000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2011 was $409000.0 (changed N/A YoY), and the FY2010 annual result was $299000.0, changed N/A from the prior year.
- Intangibles came in at $409000.0 for Q2 2011 at Guided Therapeutics, up from $299000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $409000.0 in Q2 2011 to a low of $299000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 10.34 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.14 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.62 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 409,000.00 |
| Dec 31, 2010 | 299,000.00 |